sábado, 9 de enero de 2016

Cefaleas / Headache

Enero 9, 2016. No. 2201



Tratamiento de la cefalea: abordajes farmacológicos
Pract Neurol. 2015 Dec;15(6):411-23. doi: 10.1136/practneurol-2015-001167. Epub 2015 Jul 3.
Resumen
El dolor de cabeza es una de las condiciones más comunes que se presentan en la clínica de neurología, sin embargo, una proporción significativa de estos pacientes están insatisfechos por su experiencia clínica. El dolor de cabeza puede ser extremadamente incapacitante; el tratamiento eficaz no sólo es esencial para los pacientes, pero es gratificante para el médico. En este primera revisión de dos partes sobre dolor de cabeza, ofrecemos una visión general del manejo de la cefalea, las nuevas estrategias terapéuticas y una interpretación accesible de guías clínicas para ayudar al neurólogo ocupado.
 
Headache management: pharmacological approaches.
Abstract
Headache is one of the most common conditions presenting to the neurology clinic, yet a significant proportion of these patients are unsatisfied by their clinic experience. Headache can be extremely disabling; effective treatment is not only essential for patients but is rewarding for the physician. In this first of two parts review of headache, we provide an overview of headache management, emerging therapeutic strategies and an accessible interpretation of clinical guidelines to assist the busy neurologist.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
KEYWORDS: HEADACHE; MIGRAINE
JACCOA

          
Anestesiología y Medicina del Dolor

52 664 6848905

Copyright © 2015

viernes, 8 de enero de 2016

Estimado Ciberpediatra te invito al Seminario de Pediatría, Cirugía Pediátrica y Lactancia Materna. El día 13 Enero 2016 las 21hrs (Centro, México DF, Guadalajara y Lima Perú) a la Conferencia: “Lesiones esofagicas por pilas de botón” por el“Dr. Guillermo Yanowsky Reyes”, cirujano Pediatra, de la Cd. De Guadalajara Jal La sesión inicia puntualmente las 21 hrs.
Para entrar a la Sala de Conferencia:
1.- hacer click en la siguiente liga, o cópiala y escríbela en tu buscador
http://connectpro60196372.adobeconnect.com/lesiones_pilas/
2.- “Entra como Invitado” Escribes tu nombre y apellido en el espacio en blanco
3.- Hacer click en el espacio que dice “Entrar en la Sala”
5.- A disfrutar la conferencia
6.- Recomendamos que dejes tu Nombre Completo, Correo electrónico y que participes.


Henrys


Dr. Enrique Mendoza López Webmaster: CONAPEME Coordinador Nacional: Seminario Ciberpeds-Conapeme Av La clinica 2520-310 Colonia Sertoma ,Mty N.L. México CP 64710 Tel-Fax 52 81 83482940 y 52 81 81146053 Celular 8183094806 www.conapeme.org www.pediatramendoza.com enrique@pediatramendoza.com emendozal@yahoo.com.mx

Revistas con acceso abierto / Open access journals

Enero 8, 2016. No. 2200


 



Medicine
December 2015 - Volume 94 - Issue 52pp: 1-1,e1734-e2428
Journal of Neuroanaesthesiology and Critical Care
2016 Jan-April Volume 3 | Issue 1  Page Nos. 1-76
Annals of Thoracic Medicine
January-March 2016 Volume 11 | Issue 1
Page Nos. 1-87
Anaesthesia
January 2016 Volume 71, Issue 1 Pages 3-117
Anaesthesia 
Special Issue: Peri-operative Medicine
January 2016 Volume 71, Issue Supplement S1 Pages 1-77
Revista / Journal
Pediatric Anesthesia
Special Issue: Challenging Orthodoxy
January 2015 Volume 25, Issue 1 Pages 1-110
Acta Anaesthesiologica Scandinavica
January 2015 Volume 59, Issue 1 Pages 1-136
Indian Journal of Pain
January-April 2016; Vol 30, Issue 1: page 1-69
Helen Gharaei MD.Anesthesiology and Pain Management
JACCOA


          
Anestesiología y Medicina del Dolor

52 664 6848905

Copyright © 2015

5° Curso Taller de cirugía de mano /Guadalajara / enero 21-23 2016


martes, 5 de enero de 2016

RNM y sugammadex/Neuromuscular relaxants and sugammadex


Monitoreo neuromuscular, uso de relajantes musculares, y su reversión en un hospital de enseñanza de tercer nivel 2.5. años después de introducir sugammadex. Cambios de opinión y práctica clínica
Neuromuscular monitoring, muscle relaxant use, and reversal at a tertiary teaching hospital 2.5 years after introduction of sugammadex: changes in opinions and clinical practice.
Anesthesiol Res Pract. 2015;2015:367937. doi: 10.1155/2015/367937. Epub 2015 Jan 22.
 
Parálisis residual. ¿Influencia la evolución después de cirugía ambulatoria?
Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery?
Curr Anesthesiol Rep. 2014 Dec;4(4):290-302.
Abstract
Neuromuscular blocking agents are used to facilitate tracheal intubation in patients undergoing ambulatory surgery. The use of high-dose neuromuscular blocking agents to achieve muscle paralysis throughout the case carries an increased risk of residual post-operative neuromuscular blockade, which is associated with increased respiratory morbidity. Visually monitoring the train-of-four (TOF) fade is not sensitive enough to detect a TOF fade between 0.4 and 0.9. A ratio <0.9 indicates inadequate recovery. Quantitative neuromuscular transmission monitoring (e.g., acceleromyography) should be used to exclude residual neuromuscular blockade at the end of the case. Residual neuromuscular blockade needs to be reversed with neostigmine, but it's use must be guided by TOF monitoring results since deep block cannot be reversed, and neostigmine administration after complete recovery of the TOF-ratio can induce muscle weakness. The development and use of new selectively binding reversal agents (sugammadex and calabadion) warrants reevaluation of this area of clinical practice.
KEYWORDS: Ambulatory surgery; Calabadion; NMBA; Neostigmine; PORC; Residual paralysis; Respiratory complications; Sugammadex
 

          
Anestesiología y Medicina del Dolor
52 664 6848905
vwhizar@anestesia-dolor.org
anestesia-dolor.org

Copyright © 2015

Mortalidad pediátrica en anestesia/Paediatric anaesthetic-related mortalit

Revisión de mortalidad pediátrica relacionada con anestesia. Eventos adversos severos y incidentes críticos
A review of paediatric anaesthetic-related mortality, serious adverse events and critical incidents
Larissa Cronje
South Afr J Anaesth Analg 2015; DOI: 10.1080/22201181.2015.1119503
Abstract
Anaesthetists increasingly face questions from parents on the long-term outcomes of anaesthesia, and yet more immediate anaesthetic risks are not understood, nor explained to families. This review focused on paediatric anaesthetic-related mortality, cardiac arrest and anaesthetic-related serious adverse events and critical incidents during general anaesthesia, and within 24 hours of anaesthesia ending. Anaesthetic-related mortality is rare in the developed world, and is approximately 1 per 10 000 anaesthetics, but increases in high-risk children. Serious anaesthetic-related adverse events occur in 1.4 per 1 000 anaesthetics in the developed world. Data are lacking from the developing world but anaesthetic mortality is 2-3 times higher in middle-income countries and may be up to 100-fold greater in low-income countries. A critical incident occurs in 3-8% of anaesthetics and this figure is double that in low-income countries. Anaesthetic-related events are predominantly preventable. Brief recommendations on preventative strategies are made and research goals outlined.
 
          
Anestesiología y Medicina del Dolor
52 664 6848905
vwhizar@anestesia-dolor.org
anestesia-dolor.org

Copyright © 2015